Interferon-α produces significant decreases in HIV load

Journal of Interferon and Cytokine Research

Volumn 30, Issue 7, 2010, Pages 461-464

  Tavel, Jorge A ^a   Huang, Chiung Yu ^a   Shen, Jean ^a   Metcalf, Julia A ^a   Dewar, Robin ^a   Shah, Akram ^b   Vasudevachari, M B ^b   Follmann, Dean A ^a   Herpin, Betsey ^a   Davey, Richard T ^a   Polis, Michael A ^a   Kovacs, Joseph ^c   Masur, Henry ^c   Lane, H Clifford ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANEMIA; ANOREXIA; ANTIVIRAL RESISTANCE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CD4 LYMPHOCYTE COUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEATH; DEPRESSION; DISEASE COURSE; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG EFFICACY; FATIGUE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGICAL MONITORING; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; VIREMIA; VIRUS LOAD;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HIV; HIV INFECTIONS; HUMANS; IMMUNOPHENOTYPING; INTERFERON-ALPHA; MALE; SURVIVAL ANALYSIS; VIRAL LOAD; ZIDOVUDINE;

EID: 77954940772     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0090     Document Type: Article

References (9)

1. Brassard DL, Grace MJ, Bordens RW. 2002. Interferon-a as an immu- notherapeutic protein. J Leukoc Biol 71:565-581.
2. Haas DW, Lavelle J, Nadler JP, Greenberg SB, Frame P, Mustafa N, St Clair M, McKinnis R, Dix L, Elkins M, Rooney J. 2000. A ran-domized trial of interferon alpha therapy for HIV type 1 infec-tion. AIDS Res Human Retro 16(3):183-190.
3. Kovacs JA, Deyton L, Davey R, Falloon J, Zunich K, Lee D, Metcalf JA, Bigley JW, Sawyer LA, Zoon KC, Lane HC. 1989. Combined zidovudine and interferon-a therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med lll(4):280-287.
4. Krown SE, Real FX, Cunningham-Rundles S, Myskowski PL, Koziner B, Fein S, Mittelman A, Oettgen HF, Safai B. 1983. Preliminary observations on the effect of recombinant leuko-cyte A interferon in homosexual men with Kaposi's sarcoma. N Engl J Med 308:1071-1076.
5. Pitha PM. 1994. Multiple effects of interferon on the replica-tion of human immunodeficiency virus type 1. Antiviral Res 24(2-3):205-219.
6. Shepherd FA, Beaulieu R, Gelmon K, Thuot CA, Sawka C, Read S, Singer J. 1998. Prospective randomized trial of two dose lev-els of interferon-alpha with zidovudine for the treatment of Kaposi's sarcoma associated with human immunodeficiency virus infection: a Canadian HIV Clinical Trials Network Study. J Clin Oncol 16:1736-1742.
7. Stylianou E, Yndestad A, Sikkeland LI, Berkeli V, Damas JK, Haug T, Eiken HG, Aukrust P, Froland SS. 2002. Effects of interferon- alpha on gene expression of chemokines and members of the tumour necrosis factor superfamily in HIV-infected patients. Clin Exp Immunol 130:279-285.
8. Wellferonmonograph. 2009. www.rxmed.com/b.main/b2.pharma ceutical/b2.1.monographs/CPS-%20Monographs/CPS-%20 (General%20Monographs-%20W)/ WELLFERON.html
9. Yabrov A. 2000. Is it hazardous to treat HIV patients with interfer- on-alpha? Med Hypotheses 54:131-136.